Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors-Reference-Cited by-同舟云学术

Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors

Published:2018-10-11 Issue:2 Volume:21 Page:434-438
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Dave Chintan V.¹^ORCID,Schneeweiss Sebastian¹,Patorno Elisabetta¹

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine; Brigham and Women's Hospital, Harvard Medical School; Boston Massachusetts

Funder

Harvard Medical School

National Institute on Aging

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13531/fullpdf

Reference20 articles.

1. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus;Vallon;Annu Rev Med,2015

2. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes a systematic review and meta-analysis;Vasilakou;Ann Intern Med,2013

3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

4. Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study;Patorno;BMJ,2018

5. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals;Geerlings;J Med Microbiol,1999

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative risk of infection of medications used for type 2 diabetes;Expert Opinion on Drug Safety;2024-09-11

2. Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study;Frontiers in Pharmacology;2024-08-06

3. Sodium-Glucose Cotransporter 2 Inhibitors and Mycotic Genital or Urinary Tract Infections in Heart Failure;Journal of Cardiac Failure;2024-08

4. Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Genitourinary Infections at HbA1c ≥10%: A Population Health-Based Retrospective Review;Annals of Pharmacotherapy;2024-07-29

5. Genito Urinary Infection and Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Receiving SGLT2 Inhibitors: Evidence from a Systematic Literature Review of Landmark Randomized Clinical Trial;Drug Research;2024-07-11